Allogeneic Mesenchymal Stromal Cells as a Global Pediatric Prospective Approach in the Treatment of Respiratory Failure Associated with Surfactant Protein C Dysfunction

Mesenchymal stromal cells (MSCs) have been proposed as a new therapeutic strategy to treat congenital and acquired respiratory system diseases. We describe a case report of an 18-month-old male patient with progressive chronic respiratory failure, associated with mutations of the surfactant protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelizzo, Gloria, Avanzini, Maria Antonietta, Croce, Stefania, Mandelli, Anna, Lenta, Elisa, Farolfi, Andrea, Valsecchi, Chiara, Zirpoli, Salvatore, Lanfranchi, Giulia, Durante, Eleonora, Zoia, Elena, Zuccotti, Gianvincenzo, Calcaterra, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857592/
https://www.ncbi.nlm.nih.gov/pubmed/36670712
http://dx.doi.org/10.3390/children10010162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857592/
https://www.ncbi.nlm.nih.gov/pubmed/36670712
http://dx.doi.org/10.3390/children10010162

Ejemplares similares